These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9413505)

  • 1. Comparison of gelatin particle agglutination and hemagglutination inhibition tests for measles seroepidemiology studies.
    Miyamura K; Sato TA; Sakae K; Kato N; Ogino T; Yashima T; Sasagawa A; Chikahira M; Itagaki A; Katsuki K; Matsunaga Y; Utagawa E; Takeda N; Inouye S; Yamazaki S
    Arch Virol; 1997; 142(10):1963-70. PubMed ID: 9413505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gelatin particle agglutination (PA) antibody: comparison to neutralizing antibody (NT) and hemagglutination inhibition (HI) antibody and relationship to IgG avidity].
    Saika S; Matsunaga T; Ogawa T; Ichinohe S
    Kansenshogaku Zasshi; 2008 Jul; 82(4):310-6. PubMed ID: 18697482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measles antibody followed after measles vaccination: comparison with gelatin beads agglutination (PA) antibody, hemagglutination inhibition (HI) antibody and IgG-avidity].
    Saika S; Suzuki K; Ichinohe S
    Kansenshogaku Zasshi; 2003 Oct; 77(10):809-14. PubMed ID: 14608913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a gelatin particle agglutination reagent for measles antibody assay.
    Sato TA; Miyamura K; Sakae K; Kobune F; Inouye S; Fujino R; Yamazaki S
    Arch Virol; 1997; 142(10):1971-7. PubMed ID: 9413506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiological study on prevalence of measles antibodies in Urawa City.
    Tsuji A; Tanioku Y; Nakayama T
    Keio J Med; 1998 Dec; 47(4):209-11. PubMed ID: 9884515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EIA-IgG antibody measles prevention level estimated from measles neutralizing, particle agglutination and hemagglutination-inhibition antibody titer].
    Takayama N; Saika S; Ichinohe S
    Kansenshogaku Zasshi; 2009 Sep; 83(5):519-24. PubMed ID: 19860253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between measles-neutralizing antibody and HI antibody, between measles-neutralizing antibody and PA antibody among pregnant women, and protective levels of three titration types].
    Takayama N; Shoda A; Okazaki T; Ichinohe S; Saika S; Inaba N
    Kansenshogaku Zasshi; 2007 Nov; 81(6):675-80. PubMed ID: 18095465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles antibody titre in children up to 5 years of age in rural areas of Aligarh District, India.
    Khan Z; Malik A; Pal SD; Khan MY
    Saudi Med J; 2000 Feb; 21(2):175-9. PubMed ID: 11533777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria.
    Onoja AB; Adeniji AJ
    Int J Infect Dis; 2013 Jul; 17(7):e552-5. PubMed ID: 23510540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles antibody prevalence after mass immunization campaign in Niterói, state of Rio de Janeiro, Brazil.
    Oliveira SA; Siqueira MM; Mann GF; Costa AJ; Almeida MT; Stavola MS; Tomasini H; Nascimento JP
    Rev Inst Med Trop Sao Paulo; 1996; 38(5):355-8. PubMed ID: 9293077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing seroprevalence but waning herd immunity against measles after elimination: Longitudinal seroepidemiology of measles in Osaka Prefecture, Japan, 2003-2020.
    Kurata T; Miyama T; Kanbayashi D; Kaida Y; Aoyama I; Ikemori R; Banno F; Kawahata T; Mori H; Motomura K
    Vaccine; 2022 Nov; 40(46):6581-6588. PubMed ID: 35927136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal.
    Samb B; Aaby P; Whittle HC; Seck AM; Rahman S; Bennett J; Markowitz L; Simondon F
    Pediatr Infect Dis J; 1995 Mar; 14(3):203-9. PubMed ID: 7761185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on measles immune status by ELISA].
    Li GQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):105-8. PubMed ID: 2736614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles immunity and response to revaccination of a young adult population in Israel.
    Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
    J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Standardization of neutralization tests using the COBL cell line and comparison with the particle agglutination test for measles serology].
    Korukluoğlu G; Yalçinkaya T; Ozkaya E; Kurtoğlu D; Gözalan A; Miyamura K
    Mikrobiyol Bul; 2002 Apr; 36(2):193-9. PubMed ID: 12652872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
    Hatakeyama S; Moriya K; Itoyama S; Nukui Y; Uchida M; Shintani Y; Morisawa Y; Kimura S
    Infect Control Hosp Epidemiol; 2004 Jul; 25(7):591-4. PubMed ID: 15301032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive hemagglutination test for measles immunity and serodiagnosis.
    Sakata H; Sugiura A
    J Clin Microbiol; 1988 Apr; 26(4):636-40. PubMed ID: 3130389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroepidemiology of measles in Mexico].
    Sepúlveda J; Tapia-Conyer R; Valdespino JL; Quiroz G; Salvatierra B; Zárate ML; Magos C; Llausás A; Gutiérrez G
    Salud Publica Mex; 1992; 34(2):148-56. PubMed ID: 1631729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.